Investing.com – IDEXX Labs (NASDAQ:) reported on Tuesday third quarter that beat analysts’ forecasts and revenue that topped expectations.
IDEXX Labs announced earnings per share of $2.23 on revenue of $841.66M. Analysts polled by Investing.com anticipated EPS of $2.06 on revenue of $835.19M.
IDEXX Labs shares are down 45.38% from the beginning of the year, still down 46.39% from its 52 week high of $670.92 set on November 1, 2021.
IDEXX Labs follows other major Healthcare sector earnings this month
IDEXX Labs’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
